Journal for ImmunoTherapy of Cancer (Nov 2021)

961 Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

  • Caroline Robert,
  • Helena Escuin-Ordinas,
  • Juan Martin-Liberal,
  • Miguel Sanmamed,
  • Stephane Dalle,
  • Ana Arance,
  • Marya Chaney,
  • Sorilla Prey,
  • Alfonso Berrocal,
  • Caroline Dutriaux,
  • Iván Márquez Rodas,
  • Philippe Saiag,
  • Luis de la Cruz Merino,
  • Juan Rodríguez-Moreno,
  • Eduardo Castañón Álvarez,
  • Pablo Cerezuela-Fuentes,
  • Henry Montaudie,
  • María González Cao,
  • Julie Charles,
  • María Pilar López Criado,
  • Enrique de Miguel,
  • Elisa Funk-Brentano,
  • Roberto Huertas,
  • Delvys Rodríguez Abreu,
  • Eva Muñoz Couselo,
  • Javier Sánchez López,
  • Sonia Maciá

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.961
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.